175 related articles for article (PubMed ID: 31648357)
1. A Comparison of the Currently Used Nodal Stage Classification with the Number of Metastatic Lymph Nodes and the Number of Metastatic Lymph Node Stations for Non-Small Cell Lung Cancer; Which of These Is the Best Prognostic Factor?
Citak N; Aksoy Y; Isgörücü Ö; Obuz C; Acikmese B; Buyukkale S; Metin M; Sayar A
Zentralbl Chir; 2020 Dec; 145(6):565-573. PubMed ID: 31648357
[TBL] [Abstract][Full Text] [Related]
2. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
[TBL] [Abstract][Full Text] [Related]
3. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
[TBL] [Abstract][Full Text] [Related]
4. A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non-Small Cell Lung Cancer.
Ding X; Hui Z; Dai H; Fan C; Men Y; Ji W; Liang J; Lv J; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; Lu N; He J; Wang L
J Thorac Oncol; 2016 Sep; 11(9):1565-73. PubMed ID: 27223457
[TBL] [Abstract][Full Text] [Related]
5. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
[TBL] [Abstract][Full Text] [Related]
6. Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes.
Liu H; Yan T; Zhang T; Chen X; Wang Y; Du J
Medicine (Baltimore); 2019 May; 98(20):e15645. PubMed ID: 31096486
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC.
Katsumata S; Aokage K; Ishii G; Nakasone S; Sakai T; Okada S; Miyoshi T; Tane K; Tsuboi M
J Thorac Oncol; 2019 Aug; 14(8):1408-1418. PubMed ID: 31055075
[TBL] [Abstract][Full Text] [Related]
8. Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes.
Matsuguma H; Oki I; Nakahara R; Ohata N; Igarashi S; Mori K; Endo S; Yokoi K
Eur J Cardiothorac Surg; 2012 Jan; 41(1):19-24. PubMed ID: 21620720
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
[TBL] [Abstract][Full Text] [Related]
10. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations.
Chen W; Zhang C; Wang G; Yu Z; Liu H
Thorac Cancer; 2019 Jul; 10(7):1533-1543. PubMed ID: 31207184
[TBL] [Abstract][Full Text] [Related]
12. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
[TBL] [Abstract][Full Text] [Related]
13. Number of metastatic lymph nodes and zones as prognostic factors in non-small-cell lung cancer.
Maniwa T; Ohmura A; Hiroshima T; Ike A; Kimura T; Nakamura H; Nakatsuka SI; Okami J; Higashiyama M
Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):305-314. PubMed ID: 32728705
[TBL] [Abstract][Full Text] [Related]
14. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
Fukui T; Mori S; Yokoi K; Mitsudomi T
J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
[TBL] [Abstract][Full Text] [Related]
15. Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA-IIA non-small cell lung cancer, a retrospective cohort study.
Zhai W; Duan F; Zheng Y; Yan Q; Dai S; Chen T; Chen J; Wang J
World J Surg Oncol; 2020 Sep; 18(1):258. PubMed ID: 32998771
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
Park S; Cho S; Yum SW; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer.
Lee GD; Kim DK; Moon DH; Joo S; Hwang SK; Choi SH; Kim HR; Kim YH; Park SI
Eur J Cardiothorac Surg; 2016 Feb; 49(2):580-8. PubMed ID: 25890940
[TBL] [Abstract][Full Text] [Related]
18. Which N Descriptor Is More Predictive of Prognosis in Resected Non-small Cell Lung Cancer: The Number of Involved Nodal Stations or the Location-Based Pathological N Stage?
Xu L; Su H; She Y; Dai C; Zhao M; Gao J; Xie H; Ren Y; Xie D; Chen C
Chest; 2021 Jun; 159(6):2458-2469. PubMed ID: 33352193
[TBL] [Abstract][Full Text] [Related]
19. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.
Asamura H; Chansky K; Crowley J; Goldstraw P; Rusch VW; Vansteenkiste JF; Watanabe H; Wu YL; Zielinski M; Ball D; Rami-Porta R;
J Thorac Oncol; 2015 Dec; 10(12):1675-84. PubMed ID: 26709477
[TBL] [Abstract][Full Text] [Related]
20. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
